Skip to main content
OpenTrials
Completed

NCT Number: NCT06476483

Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit

This study aims to understand if implementing DIALOG+ in an inpatient psychiatric rehabilitation setting is feasible (can the intervention be implemented) and acceptable (how the intervention is perceived by staff and patient participants). If the intervention is proven to be feasible and acceptable a larger-scale study may take place. This study has been developed in response to the trust-wide implementation of DIALOG outcome measures. DIALOG+ offers additional solution-focused and person-centred follow-up questions to the DIALOG questions and links to multidisciplinary team (MDT) discussions. It is hoped that the conversations had during DIALOG+ meetings will support positive outcomes, and the learning gathered from this study will drive change and improvement for other people requiring psychiatric rehabilitation inpatient admissions in the future. DIALOG+ has been successfully implemented in community settings in the national health service (NHS) but has not been implemented in psychiatric rehabilitation inpatient settings. This study will aim to recruit patient and staff participants from NHS psychiatric rehabilitation inpatient wards. Patient participants who will be eligible to take part are those who can consent, are between the ages of 18-65, and can complete DIALOG and DIALOG+. To understand the feasibility of the intervention, descriptive statistics will be collected and to understand acceptability focus groups will take place and surveys will be collected. Quantitative data collection will take place over 5 months and will be split into 2 groups. Group one will be a comparison group where participants will act as an extended baseline group and biweekly DIALOG outcomes will be collected. Group 2 will be a Treatment group and participants will receive the DIALOG+ intervention intervention, DIALOG outcomes will be collected biweekly as part of the intervention. Finally, there will be a period to gather qualitative feedback from patient participants using surveys, and from staff participants using focus groups or semi-structured interviews.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychological Recovery

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Forest Close

Sheffield, South Yorkshire, s35 0jw, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18-65
  • Capacity to give informed consent as determined by the MDT and through following informed consent processes.
  • Admitted into the inpatient ward
  • Can complete DIALOG and DIALOG+

Exclusion criteria

  • No capacity to consent
  • Insufficient command of the English language

Treatment and study plan

DIALOG+

Behavioral

A person-centred and solution-focused intervention linked to the DIALOG outcome measure (a measure of patient experience and quality of life).

DIALOG

Behavioral

An outcome measure consisting of 11 questions, with 8 related to quality of life and 3 items on treatment satisfaction. Patients can rate their satisfaction on a 7-point scale for each of the 8 life domains and 3 treatment aspects, resulting in scores for both quality of life and treatment satisfaction. The DIALOG scale does not provide any guidance for patient and clinician interactions.

Primary outcomes

  1. Feasibility outcome- Recruitment rate/consent rate

    Time frame: assessed at the end of the study (after 5 months)

    The number of people who agreed and consented to participate in the study out of the total number of eligible participants approached. Reported as a percentage.

  2. Feasibility outcome- Number of eligible participants.

    Time frame: assessed at the end of the study (after 5 months)

    Eligible participants are those who meet the inclusion criteria, reported as a count of participants.

  3. Feasibility outcome- Participation rate

    Time frame: assessed at the end of the study (after 5 months)

    The proportion of those who consented and agreed to engage in DIALOG and DIALOG+ out of the number of participants who engaged in the intervention after consenting. Reported as a percentage of participants.

  4. Feasibility outcome- Completion rate

    Time frame: assessed at the end of the study (after 5 months)

    The proportion of those who completed the intervention out of the number who consented and engaged in DIALOG and DIALOG+. Reported as a percentage of participants.

  5. Feasibility outcome- Drop out rate

    Time frame: assessed at the end of the study (after 5 months)

    The number of participants who completed the intervention out of total number of patients enrolled. Reported as a percentage of participants.

  6. Feasibility outcomes- Reasons for drop out

    Time frame: assessed at the end of the study (after 5 months)

    Reasons for drop out will be assessed when by asking the participant after drop out.

  7. Feasibility outcomes- Follow up rate

    Time frame: assessed at the end of the study (after 5 months)

    The number of patients willing to engage in follow-up surveys related to the study out of the total number of participants enrolled in the study. Reported as a percentage of participants.

  8. Feasibility outcome- The willingness of clinicians to recruit participants

    Time frame: assessed at the end of the study (after 5 months)

    Number of staff members who attend DIALOG+ training and implement intervention out of the total number of staff offered to participate. Reported as a percentage.

  9. Feasibility outcome- Average number of DIALOG+ sessions

    Time frame: assessed at the end of the study (5 months)

    Reported as the average number of participants.

  10. Acceptability outcome- Cost

    Time frame: assessed at the end of the study (after 5 months)

    Analysing the cost and benefits of implementing the intervention (including staff training). Reported as a total amount or duration of time spent on training (minutes).

  11. Number of staff participants who find DIALOG and DIALOG+ feasible and acceptable to implement in an inpatient rehabilitation setting. Assessed using thematic analysis of focus groups.

    Time frame: assessed at the end of the study (after 5 months)

    To assess the acceptability of the intervention a theoretical framework (Sekhon et al., 2017) was used. Feasibility objectives are defined by Bugge et al., 2013. Focus group transcripts will be subject to a qualitative thematic analysis. Analysis of focus groups will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview with in relation to the research question (Braun & Clarke, 2006).

  12. Number of patients who find it feasible and acceptable to implement DIALOG and DIALOG+ in an inpatient rehabilitation setting. Assessed using thematic analysis and average scores of patient surveys.

    Time frame: assessed at the end of the study (after 5 months)

    The questionnaires will be a mixture of open ended questions and Likert Scale questions based on questions asked by Matanov et al. (2021), 8 of the questions are scored on a Likert scale (1-5). The survey will be given to patients post-intervention. Questions on the scale have been specifically developed to assess feasibility and acceptability of DIALOG+. An average total score will be used in the analysis of Likert scale questions. Open-ended questionnaire responses will be subject to a qualitative thematic analysis. Analysis will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview in relation to the research question (Braun & Clarke, 2006).

Secondary outcomes

  1. DIALOG questionnaire

    Time frame: At the beginning of the study, then biweekly for a duration of 5 months with the final measure taken after 5 months

    The DIALOG questionnaire consists of 11 questions, with 8 items related to subjective quality of life (SQOL) and 3 items on treatment satisfaction. Patients can rate their satisfaction on a 7-point scale for each of the 8 life domains and 3 treatment aspects, resulting in scores for both SQOL and treatment satisfaction. An increase in score indicates improvement.

    The dependent variable will be DIALOG outcomes at the end of intervention or discharge and the independent variable will be the group binary variable (intervention or comparison group). Data will be analysed using a linear regression model to assess whether implementing DIALOG+ as an intervention in addition to using the DIALOG outcome measure, leads to improved outcomes.

    The unit of measure: reported as an average total score.

  2. Demographic information

    Time frame: assessed at the end of the study (5 months)

    To gather demographic details from patients to assess the potential generalisability of DIALOG and DIALOG+. • Demographic information includes age, gender, ethnicity, history of mental illness or previous inpatient admissions, drug-use, diagnosis, baseline severity on DIALOG, and length of stay. Reported as a percentage of participants.

  3. Length of admission in months

    Time frame: assessed at the end of the study (5 months)

    To use regression analysis to understand the effectiveness of the intervention and impact on admission length and DIALOG score.

Sponsors and collaborators

Lead sponsor

University of Sheffield

Other

Collaborators

  • National Health Service, United Kingdom

Registry information

Official study title

Implementing the DIALOG Outcome Measure and a Solution-Focused Intervention (DIALOG+) in a Rehabilitation Psychiatric Inpatient Setting: A Mixed Methods Feasibility Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 26, 2024
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.